- Home
- ORIC vs EU Comparison
ORIC vs EU Comparison
Compare ORIC & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- EU
- Stock Information
- Founded
- ORIC 2014
- EU 2009
- Country
- ORIC United States
- EU United States
- Employees
- ORIC N/A
- EU N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- EU Other Metals and Minerals
- Sector
- ORIC Health Care
- EU Basic Materials
- Exchange
- ORIC Nasdaq
- EU Nasdaq
- Market Cap
- ORIC 633.7M
- EU 652.4M
- IPO Year
- ORIC 2020
- EU N/A
- Fundamental
- Price
- ORIC $9.85
- EU $3.56
- Analyst Decision
- ORIC Strong Buy
- EU Strong Buy
- Analyst Count
- ORIC 9
- EU 2
- Target Price
- ORIC $18.75
- EU $6.50
- AVG Volume (30 Days)
- ORIC 585.0K
- EU 1.4M
- Earning Date
- ORIC 03-10-2025
- EU 11-14-2024
- Dividend Yield
- ORIC N/A
- EU N/A
- EPS Growth
- ORIC N/A
- EU N/A
- EPS
- ORIC N/A
- EU N/A
- Revenue
- ORIC N/A
- EU $44,972,063.00
- Revenue This Year
- ORIC N/A
- EU N/A
- Revenue Next Year
- ORIC N/A
- EU $55.73
- P/E Ratio
- ORIC N/A
- EU N/A
- Revenue Growth
- ORIC N/A
- EU N/A
- 52 Week Low
- ORIC $6.33
- EU $3.02
- 52 Week High
- ORIC $16.65
- EU $5.05
- Technical
- Relative Strength Index (RSI)
- ORIC 56.99
- EU 54.33
- Support Level
- ORIC $9.39
- EU $3.26
- Resistance Level
- ORIC $11.15
- EU $3.60
- Average True Range (ATR)
- ORIC 0.75
- EU 0.18
- MACD
- ORIC 0.20
- EU 0.01
- Stochastic Oscillator
- ORIC 62.92
- EU 52.54
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
About EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's material properties and projects are the Rosita Project located in Texas, the Alta Mesa Uranium project in Texas, the Crownpoint and Hosta Butte Uranium Project located in New Mexico, the Dewey Burdock Project located in South Dakota, and the Gas Hills Project located in Wyoming.